Prime Medicine, Inc.
PRME Nasdaq
SEC CIK 1894562
Follow Prime Medicine
Weekly email: filings, results
Revenue, last quarter
$4.2M
+243.9% vs same quarter last year
Net income
−$39M
+22.8% vs same quarter last year
EPS, diluted
−$0.22
+31.3% vs same quarter last year
Operating cash flow
−$36.7M
−4.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $4.6M | −$201.1M |
| FY24 | $3M | −$195.9M |
| FY23 | $0 | −$198.1M |
| FY22 | $0 | −$121.8M |
| FY21 | $0 | −$165.4M |
| FY20 | $5.2M | −$3.4M |
| FY19 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −4498.1% | −4342.4% |
| FY24 | −6787.4% | −6566.6% |
| FY23 | - | - |
| FY22 | - | - |
| FY21 | - | - |
| FY20 | −17.9% | −65.5% |
| FY19 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$167.1M |
| FY24 | −$130.2M |
| FY23 | −$174.1M |
| FY22 | −$147.9M |
| FY21 | −$38.2M |
| FY20 | −$6.2M |
| FY19 | - |
- Prime Medicine
- Healthcare median
Show the numbers
| Year | Prime Medicine | Healthcare median |
|---|---|---|
| FY25 | −4342.4% | −30.6% |
| FY24 | −6566.6% | −47% |
| FY23 | - | −58% |
| FY22 | - | −80.4% |
| FY21 | - | −71.8% |
| FY20 | −65.5% | −62.2% |
| FY19 | - | −46.2% |